BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17237474)

  • 1. CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.
    Keshaviah A; Dellapasqua S; Rotmensz N; Lindtner J; Crivellari D; Collins J; Colleoni M; Thürlimann B; Mendiola C; Aebi S; Price KN; Pagani O; Simoncini E; Castiglione Gertsch M; Gelber RD; Coates AS; Goldhirsch A
    Ann Oncol; 2007 Apr; 18(4):701-8. PubMed ID: 17237474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum CA15-3 levels correlate with positive estrogen receptor and initial favorable outcome in patients who died from recurrent breast cancer.
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H
    Breast Cancer; 2003; 10(3):220-7. PubMed ID: 12955034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between cancer antigen 15.3 value and qualitative and semiquantitative parameters of positron emission tomography/computed tomography in breast cancer patients.
    Cervino AR; Saibene T; Michieletto S; Ghiotto C; Bozza F; Saladini G; Evangelista L
    Curr Radiopharm; 2014; 7(1):20-8. PubMed ID: 24836946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry.
    Nam SE; Lim W; Jeong J; Lee S; Choi J; Park H; Jung YS; Jung SP; Bae SY
    Breast Cancer Res Treat; 2019 Oct; 177(3):669-678. PubMed ID: 31312932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH).
    Said NM
    Mol Biol Rep; 2019 Apr; 46(2):2013-2027. PubMed ID: 30706358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer?
    Velaiutham S; Taib NA; Ng KL; Yoong BK; Yip CH
    Asian Pac J Cancer Prev; 2008; 9(3):445-8. PubMed ID: 18990019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients.
    Incoronato M; Mirabelli P; Catalano O; Aiello M; Parente C; Soricelli A; Nicolai E
    BMC Cancer; 2014 May; 14():356. PubMed ID: 24886519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomically Co-dispersed nitrogen-doped carbon for sensitive electrochemical immunoassay of breast cancer biomarker CA15-3.
    Han L; Cai S; Chen X
    Mikrochim Acta; 2024 Jun; 191(7):370. PubMed ID: 38837084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.
    Gion M; Mione R; Leon AE; Dittadi R
    Clin Chem; 1999 May; 45(5):630-7. PubMed ID: 10222349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
    Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
    World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancer.
    Nisman B; Maimon O; Allweis T; Kadouri L; Maly B; Hamburger T; Peretz T
    Anticancer Res; 2013 Jan; 33(1):293-9. PubMed ID: 23267160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of CA15.3 in 7942 patients with operable breast cancer.
    Sandri MT; Salvatici M; Botteri E; Passerini R; Zorzino L; Rotmensz N; Luini A; Mauro C; Bagnardi V; Cassatella MC; Bottari F; Casadio C; Colleoni M
    Breast Cancer Res Treat; 2012 Feb; 132(1):317-26. PubMed ID: 22065291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.
    Arslan N; Serdar M; Deveci S; Ozturk B; Narin Y; Ilgan S; Ozturk E; Ozguven MA
    Ann Nucl Med; 2000 Oct; 14(5):395-9. PubMed ID: 11108173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer.
    Chen Z; Xu S; Su D; Liu W; Yang H; Xie S; Meng X; Lei L; Wang X
    Clin Transl Oncol; 2015 Jun; 17(6):486-94. PubMed ID: 25511546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Preoperative Ki67 and Serum CA15.3 Levels with Outcome in Early Breast Cancers a Multi Institutional Study.
    Rasmy A; Abozeed W; Elsamany S; Baiomy ME; Nashwa A; Amrallah A; Hasaan E; Alzahrani A; Faris M; Alsaleh K; AlFaraj A
    Asian Pac J Cancer Prev; 2016; 17(7):3595-600. PubMed ID: 27510014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte alkaline phosphatase, CA15-3, CA125, and CEA in cancer patients.
    Walach N; Gur Y
    Tumori; 1998; 84(3):360-3. PubMed ID: 9678617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pre-operative serum CA 15.3 levels in breast cancer.
    Martín A; Corte MD; Alvarez AM; Rodriguez JC; Andicoechea A; Bongera M; Junquera S; Pidal D; Allende T; Muñiz JL; Vizoso F
    Anticancer Res; 2006; 26(5B):3965-71. PubMed ID: 17094428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.